Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04754022 · ClinicalTrials.gov registry record · NA
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
A NA study of Cardiac Surgery and Heart, sponsored by Unity Health Toronto.
- Recruiting
- Registry status
- NA
- Development phase
- 1,440
- Enrollment target
- 20
- Study locations
NCT04754022 is a NA study of Cardiac Surgery and Heart that is actively recruiting participants, run by Unity Health Toronto. The registered enrollment target is 1,440 participants, above the 670-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (115% higher). The trial reports 20 study locations across 14 states.
The verdict
NCT04754022, a NA study of Cardiac Surgery and Heart, is actively recruiting participants, sponsored by Unity Health Toronto.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,440 participants
- Enrollment target
- 20
- Study locations
Study Summary
TRICS-IV is an international, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in moderate to high risk patients who are 65 years of age or younger undergoing cardiac surgery on cardiopulmonary bypass, using a superiority trial design.
Conditions Studied
Interventions
- OTHER Restrictive Transfusion Strategy
- OTHER Liberal transfusion strategy
Study Locations (20)
New South Wales
- Royal Prince Alfred hospital - Camperdown
- Prince of Wales Hospital - Randwick
- Westmead Hospital - Westmead
Victoria
- Monash Health - Clayton
- St Vincent's Hospital Melbourne - Fitzroy
- Austin Health - Heidelberg
Other
- Royal Melbourne Hospital - Melbourne
- Alfred Hospital - Prahran
British Columbia
- Interior Health Kelowna General Hospital - Kelowna
- Vancouver General Hospital - Vancouver
Maine
- Maine Medical Center - Portland
New Jersey
- The Cooper Health System - Camden
New York
- Columbia University - New York
Pennsylvania
- Thomas Jefferson University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,440 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04754022
The ClinicalTrials.gov registry entry for NCT04754022 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,440 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 670-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (115% higher). The listed sponsor is Unity Health Toronto, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cardiac Surgery appearing as the primary indexed condition, and to 2 interventions - of which Restrictive Transfusion Strategy is the first listed.
NCT04754022 reports 20 study locations spanning 14 distinct geographic areas - top geographies include New South Wales, Victoria, Other.
Frequently Asked Questions
What is clinical trial NCT04754022 about?
NCT04754022 is a clinical study titled "Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery". TRICS-IV is an international, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in moderate to high risk patients who are 65 years of age or younger undergoing cardiac surgery on cardiopulmonary bypass, using a superiority trial design.
What is the current status of trial NCT04754022?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,440 participants. The study started on 2021-11-01. Estimated completion is 2026-06.
What conditions does trial NCT04754022 study?
This clinical trial studies the following conditions: Cardiac Surgery, Heart, Postoperative, Disorder.
What interventions are being tested in trial NCT04754022?
The interventions under investigation include: Restrictive Transfusion Strategy (OTHER), Liberal transfusion strategy (OTHER).
Who is sponsoring clinical trial NCT04754022?
This trial is sponsored by Unity Health Toronto, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04754022 being conducted?
This trial has 20 study locations across Maine, New Jersey, New York, Pennsylvania, Adelaide. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Low Tidal Volume Ventilation With Hyperoxia Avoidance During Cardiopulmonary Bypass (The FOCUS Trial)
ACTIVE NOT RECRUITING · NA
-
A Randomized Clinical Trial to Measure Efficacy of Music on Cardiac Surgery Patients
ACTIVE NOT RECRUITING · NA
-
Remote Ischemic Preconditioning in Cardiac Surgery Trial
COMPLETED · NA
-
Oral Methadone in Cardiac Surgery
RECRUITING · Phase 4
-
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
RECRUITING
-
Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.